Dr. Elizabeth Jane Kream, MD

Dr. Kream practices at Schweiger Dermatology PLLC in Long Island City, New York.

Dr. Kream's NPI, 1790275071, was assigned on May 13, 2018. Dr. Kream graduated from Tulane University School of Medicine in 2018. Dr. Kream holds New York license 125073240.

Dr. Kream's primary practice is Schweiger Dermatology PLLC, at 27-1 Queens N Plz, Long Island City, NY 11101 in Queens County. The practice phone is (212) 283-3000.

Dr. Kream's primary practice is Schweiger Dermatology PLLC in Long Island City, New York. The medical group on file is Schweiger Dermatology Group. Dmand AI also links Dr. Kream to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kream practices. Vendor and product names are available with a free account.

Dermatology is Dr. Kream's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Kream is licensed in New York.

CMS data shows 607 Medicare services from Dr. Kream across 12 procedure codes in 2024, for 190 Medicare patients. Medicare paid $34,138 for them. Every service was in an office.

CMS counts 190 Medicare patients who saw Dr. Kream in 2024. The largest group is 65 to 74, with 92 patients. 71% of them have high cholesterol, and 53% have high blood pressure. 7% are also on Medicaid. Their average risk score is 0.79, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kream's median patient age at 44, with 55% women.

In 2024, Dr. Kream wrote 375 Medicare Part D claims for 136 patients. 88% of them were for generic drugs. CMS names the drug for 271 of them, across 8 drugs with 11 or more claims each, at $49,141 in total drug cost. In 2023, CMS named 28 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Kream for performance year 2024, reported as part of a group.

Dmand AI links 12 papers to Dr. Kream, published from 2021 to 2023. 2022 was the busiest year, with 2. The most frequent topics are Cosmetic Techniques, Social Media and Dermatology. Dr. Kream has published most often in Dermatol Surg. Dr. Kream's most frequent co-authors are Jeffrey Steven Dover, MD, Sabrina Guillen Fabi, MD and Roy G. Geronemus, MD.

CMS Open Payments shows 485 general payments to Dr. Kream from 27 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $1,977.

Dr. Kream graduated from Tulane University School of Medicine in 2018.